Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-week Randomized, Controlled Trial to Compare TOUJEO® and TRESIBA® in Terms of Glucose Values in Target Range and Variability During Continuous Glucose Monitoring in Patients With Type 1 Diabetes Mellitus

NCT04075513 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT04075513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04075513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-week Randomized, Controlled Trial to Compare TOUJEO® and TRESIBA® in Terms of Glucose Values in Target Range and Variability During Continuous Glucose Monitoring in Patients With Type 1 Diabetes Mellitus
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
October 9, 2019
Completion date
September 16, 2021
Enrollment
343 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus